pharma

Showing 15 posts of 2914 posts found.

Sanofi’s Dupixent extended in Europe to cover adolescents in atopic dermatitis

August 6, 2019
Manufacturing and Production, Sales and Marketing EU, Europe, Sanofi, atopic dermatits, pharma

Sanofi has announced that European Commission (EC) has chosen to extend the marketing approval of its interleukin-4 (IL-4) and interleukin-13 …

Pfizer’s sickle cell drug flops at Phase 3 trial

August 6, 2019
Manufacturing and Production, Sales and Marketing Pfizer, Sickle cell, clinical trials, pharma, reset

Pfizer has said its sickle cell drug rivipansel failed to meet its primary endpoint or key secondary endpoints in a …

vaila_morrison

Living with a rare genetic neurodevelopmental disorder

August 5, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing KAT6A, feature, patient experience, pharma, rare disease

Vaila Morrison’s daughter Eilidh was born with the ultra-rare condition KAT6A. As a designer and architect by profession, Vaila told …

headquarters_ingelheim3

Additional data for Boehringer’s Giotrif combo shows strong overall survival benefit in lung cancer sub-population

August 5, 2019
Research and Development, Sales and Marketing Boehringer Ingelheim, Cancer, giotrif, lung cancer, pharma

German firm Boehringer Ingelheim has released new interim data from a real-world evidence study investigating the efficacy of Giotrif/Gilotrif (afatinib) …

394px-ad_versus_co

New model can help predict cognitive decline in patients with Alzheimer’s

August 5, 2019
Sales and Marketing Alzheimer's pharma, cognitive decline, computing, dementia, pharma

Scientists at MIT have developed a new model which can predict whether patients at risk for Alzheimer’s disease will experience …

Pollen spores could be used to protect potent, ocean-dwelling antibiotics in fighting antibiotic resistant superbugs

August 5, 2019
Research and Development, Sales and Marketing AMR, Antibiotics, MRSA, club moss, pharma, pollen, spores

Spores from a plant called the common club moss (Lycopodium clavatum) could be used to protect light-sensitive antibiotics, that are …

index_ph001

Daiichi Sankyo’s Turalio becomes first FDA-approved therapy for rare tumour

August 5, 2019
Sales and Marketing Cancer, Daiichi Sankyo, FDA, Turalio, US, pharma, rare cancer

Daiichi Sankyo has seen its CSF1R inhibitor Turalio (pexidartinib) approved by the FDA in the treatment of symptomatic tenosynovial giant …

shutterstock_141299494

Top UK doctors warn Boris Johnson that no-deal Brexit would cause key cancer therapy supply shortages

August 2, 2019
Manufacturing and Production, Medical Communications Cancer, NHS, UK, brexit, pharma

Top doctors from some of the UK’s foremost nuclear medicine associations have written a letter to recently-anointed Prime Minister Boris …

AI accurately detects subtle signs of atrial fibrillation even in normal tests

August 2, 2019
Medical Communications AF, AI, ECG, atrial fibrillation, electrcardiogram, pharma

A new study from the Mayo Clinic shows that artificial intelligence (AI) can detect signs of atrial fibrillation (AF) in …

nucala-web

European approval for two new delivery formulations of GSK’s Nucala in severe eosinophilic asthma

August 2, 2019
Medical Communications, Sales and Marketing Europe, GSK, Nucala, asthma, pharma

Following closely on the heels of the news that its deal to merge Pfizer’s consumer health business with its own, …

novartis_outside_1

Novartis’ Kisqali reinforces overall survival benefit in postmenopausal HR+/HER2- breast cancer

August 1, 2019
Research and Development Cancer, Kisqali, Novartis, breast cancer, pharma

New Phase 3 evidence has emerged on the efficacy of Novartis’ Kisqali (ribociclib) in combination with AstraZeneca’s Faslodex (fulvestrant) in …

shutterstock_273326141

GSK closes the deal with Pfizer over $9.8 billion consumer healthcare merger

August 1, 2019
Sales and Marketing GSK, Pfizer, merger, pharma

The $9.8 billion joint venture between major pharma firms GlaxoSmithKline and Pfizer to merge their consumer health operations has come …

Bayer’s Xarelto combo greenlighted by NICE for reducing CV events in artery disease

August 1, 2019
Sales and Marketing NHS, NICE, UK, Xarelto, cardiovascular disease, pharma

NICE has awarded final appraisal recommendation to Bayer’s Xarelto (rivaroxaban) at a dosage of 2.5mg twice daily in combination with …

FDA steps up 2018 drug approvals by 11% on previous year

August 1, 2019
Sales and Marketing EMA, FDA, drug approvals, pharma

The FDA continues to excel in the ground it covers as it emerges that the total number of new drug …

The Gateway to Local Adoption Series

Latest content